- Acute Promyelocytic Leukemia After Radium-223 Exposure for Prostate Cancer in a Chemotherapy-Naïve Patient
-
Perrone S, Barbera EOL, Ottone T, Capriata M, Passucci M, Filippi L, Bagni O, Voso MT, Cimino G
- KMID: 2507744
- Nucl Med Mol Imaging.
- 2020 Oct;54(5):256-260.
- doi: 10.1007/s13139-020-00652-9
223Ra-dichloride is a bone-seeking targeted alpha (α)-emitting approved for bone metastases in prostate cancer. Here, we report a case of therapy-related acute promyelocytic leukemia (t-APL) following administration of 223Ra, showing... -
- CITED
-
- Close
- SHARE
-
- Close
- Imaging Findings of 18F‑Choline and 18F‑DOPA PET/MRI in a Case of Glioblastoma Multiforme Pseudoprogression: Correlation with Clinical Outcome
-
Filippi L, Spanu A, Bagni O, Schillaci O, Palumbo B
- KMID: 2534412
- Nucl Med Mol Imaging.
- 2022 Oct;56(5):245-251.
- doi: 10.1007/s13139-022-00758-2
We describe the case of 74-year-old-male, previously treated with fronto-parietal craniotomy due to primary glioblastoma multiforme (GBM), followed by concurrent radiation therapy (RT) and temozolomide (TMZ) chemotherapy. Magnetic resonance imaging... -
- CITED
-
- Close
- SHARE
-
- Close
- Sequential Use of 90Y Microspheres Radioembolization and 177Lu-Dotatate in Pluri-Metastatic Neuroendocrine Tumors: A Case Report
-
Filippi L, Ciorra A, Sardella B, Schillaci , Bagni O
- KMID: 2313218
- Nucl Med Mol Imaging.
- 2014 Dec;48(4):321-325.
- doi: 10.1007/s13139-014-0292-2
90Y radioembolization and peptide-receptor radionuclide therapy (PRRT) with177Lu-DOTATATE are both effective treatments for patients with inoperable neuroendocrine metastatic tumors (NET). We report the case of a 72-year-old man with severe... -
- CITED
-
- Close
- SHARE
-
- Close
